Objective: The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
ICICI Prudential Nifty Pharma Index Fund Direct Growth is an Equity - Index Funds fund. The fund was launched inDec 15, 2022. Its risk level is . The NAV of the fund as onAug 04, 2025 is ₹17.15. Its expense ratio is 0.30 %. The fund has an AUM of ₹91.49 Cr.The fund is managed byKayzad Eghlim,Nishit Patel,Priya Sridhar,Kewal Shah,Ashwini Shinde.
The minimum initial investment is ₹1000 in Lumpsum mode.